Literature DB >> 31039564

What Have We Learned about the Use of Cytosorb Adsorption Columns?

Ghada Ankawi1,2, Yun Xie3,4, Bo Yang3,5, Yuanyuan Xie3,6, Pan Xie3,7, Claudio Ronco3,8.   

Abstract

Extracorporeal blood purification techniques have emerged and evolved in the recent years as a potential therapy for the purpose of immunomodulation in acute conditions like sepsis. Understanding the extent of immune system dysregulation involved in the pathophysiology of these conditions, resulted in the development of such treatment strategies aiming at restoring a balanced inflammatory response. Beyond conventional continuous renal replacement therapy, high volume hemofiltration, high cut-off membranes, adsorption alone and coupled plasma filtration adsorption are well-described techniques in the literature. The evidence to support their routine use, however, is conflicting and insufficient at this stage. Despite the low-quality level of evidence in favor of utilizing these techniques, studies to further explore their effectiveness, safety, and potential novel applications, continue to evolve. Our review aims at focusing on adsorption therapy, particularly using the adsorption columns Cystosorb.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Adsorption; Cardiac surgery; Cytokines; Extracorporeal therapy; Sepsis; Sorbents

Mesh:

Year:  2019        PMID: 31039564     DOI: 10.1159/000500013

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  20 in total

1.  Reducing antithrombotic-related bleeding risk in urgent and emergency cardiac surgery.

Authors:  Amer Harky; Abdul Badran
Journal:  Br J Cardiol       Date:  2021-06-02

2.  Cytokine Adsorption in Cardiac Surgery: where do we stand?

Authors:  Rohan Magoon; Manpal Loona; Jasvinder Kaur Kohli; Ramesh Kashav
Journal:  Braz J Cardiovasc Surg       Date:  2020-06-01

3.  CytoSorb removes MDMA in vitro, but is it an effective therapy in vivo?

Authors:  Patrick M Honore; Sebastien Redant; Thomas Datzmann
Journal:  Intensive Care Med Exp       Date:  2020-07-29

4.  Extracorporeal cytokine adsorption: Significant reduction of catecholamine requirement in patients with AKI and septic shock after cardiac surgery.

Authors:  Kristina Boss; Michael Jahn; Daniel Wendt; Zaki Haidari; Ender Demircioglu; Matthias Thielmann; Arjang Ruhparwar; Andreas Kribben; Bartosz Tyczynski
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

5.  Influence of hemoadsorption during cardiopulmonary bypass on blood vesicle count and function.

Authors:  Lukas Wisgrill; Christian Lamm; Lena Hell; Johannes Thaler; Angelika Berger; Rene Weiss; Viktoria Weber; Harald Rinoesl; Michael J Hiesmayr; Andreas Spittler; Martin H Bernardi
Journal:  J Transl Med       Date:  2020-05-15       Impact factor: 5.531

6.  Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not.

Authors:  Patrick M Honore; Sebastien Redant; David De Bels
Journal:  Crit Care       Date:  2020-09-11       Impact factor: 9.097

7.  Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: si vis pacem para bellum.

Authors:  Claudio Ronco; Thiago Reis; Silvia De Rosa
Journal:  Blood Purif       Date:  2020-03-13       Impact factor: 2.614

8.  Use of the CytoSorb adsorption device in MDMA intoxication: a first-in-man application and in vitro study.

Authors:  Corinna N Lang; Michaela J Sommer; Merja A Neukamm; Dawid L Staudacher; Alexander Supady; Christoph Bode; Daniel Duerschmied; Achim Lother
Journal:  Intensive Care Med Exp       Date:  2020-06-15

Review 9.  Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress.

Authors:  Huan Lin; Wenting Wang; Madeline Lee; Qinghe Meng; Hongsheng Ren
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

10.  Hemoadsorption Improves Survival of Rats Exposed to an Acutely Lethal Dose of Aflatoxin B1.

Authors:  Karl-Gustav Ruggeberg; Pamela O'Sullivan; Timothy J Kovacs; Kathryn Dawson; Vincent J Capponi; Phillip P Chan; Thomas D Golobish; Maryann C Gruda
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.